Taken together, our results revealed that the transcriptional activity of β-catenin could be modulated by the CK1δ/ε-β-catenin-Tip60 axis, which may be a potential therapeutic target for colon cancer. The gene discussed is KAT5; the disease is malignant colon neoplasm.